1 Spectacular Growth Stock Down 34% to Buy Hand Over Fist [Yahoo! Finance]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Yahoo! Finance
One less stressful way to take part in the booming industry is to invest in "picks-and-shovels" companies that support biotech stocks but aren't reliant upon any single clinical trial outcome to profit. A successful company that fits this billing is Medpace (NASDAQ: MEDP) , a leading clinical contract research organization. Medpace offers a full suite of development services for small to medium-sized biotechs, helping them get from phase I to phase IV (and beyond) in the clinical trial process. Serving this niche, Medpace has been an 11-bagger since its initial public offering (IPO) in 2016 -- quintupling the S&P 500 's total returns over the same time. Despite this promising run, however, funding in the cyclical biotech industry declined over the last year, causing Medpace's growth to slow and its share price to plummet 34%. Though this share price drop may seem alarming, I believe Medpace is positioned to rebound -- just as it has in the past -- and makes for a spectacular growt
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace (NASDAQ:MEDP) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- How Medpace's Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings (MEDP) Investors [Yahoo! Finance]Yahoo! Finance
- 2 Profitable Stocks to Keep an Eye On and 1 We Find Risky [Yahoo! Finance]Yahoo! Finance
- Medpace (MEDP): Assessing Valuation After Revenue Growth, Buybacks and AI-Driven Clinical Trial Expansion [Yahoo! Finance]Yahoo! Finance
- Medpace Holdings, Inc. (MEDP): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
MEDP
Earnings
- 10/22/25 - Beat
MEDP
Sec Filings
- 12/9/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- MEDP's page on the SEC website